Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Curtin

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Research Synthesis Methods|April 22, 2017
Meta-analysis combining parallel and cross-over trials with random effectsFrançois Curtin
Research Synthesis Methods|June 7, 2017
Meta-analysis combining parallel and crossover trials using generalised estimating equation methodFrançois Curtin
Journal of Affective Disorders|March 12, 2004
Clonazepam and lorazepam in acute mania: a Bayesian meta-analysisFrançois Curtin, Pierre Schulz
Drug Safety|August 15, 2020
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety ReviewGabrielle Kornmann, François Curtin
Dialogues in Clinical Neuroscience|August 17, 2011
Assessing the benefit: risk ratio of a drug--randomized and naturalistic evidenceFrançois Curtin, Pierre Schulz
Expert Review of Clinical Pharmacology|April 25, 2017
The role of adaptive trial designs in drug developmentFrançois Curtin, Stephane Heritier
Expert Review of Clinical Pharmacology|December 12, 2013
Novel therapeutic options for multiple sclerosisFrançois Curtin, Hans-Peter Hartung
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-overFrançois Curtin, Diana Elbourne, Douglas G Altman
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomesFrançois Curtin, Douglas G Altman, Diana Elbourne
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrançois Curtin, Diana Elbourne, Douglas G Altman
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Research Synthesis Methods|April 22, 2017
Meta-analysis combining parallel and cross-over trials with random effectsFrançois Curtin
Research Synthesis Methods|June 7, 2017
Meta-analysis combining parallel and crossover trials using generalised estimating equation methodFrançois Curtin
Journal of Affective Disorders|March 12, 2004
Clonazepam and lorazepam in acute mania: a Bayesian meta-analysisFrançois Curtin, Pierre Schulz
Drug Safety|August 15, 2020
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety ReviewGabrielle Kornmann, François Curtin
Dialogues in Clinical Neuroscience|August 17, 2011
Assessing the benefit: risk ratio of a drug--randomized and naturalistic evidenceFrançois Curtin, Pierre Schulz
Expert Review of Clinical Pharmacology|April 25, 2017
The role of adaptive trial designs in drug developmentFrançois Curtin, Stephane Heritier
Expert Review of Clinical Pharmacology|December 12, 2013
Novel therapeutic options for multiple sclerosisFrançois Curtin, Hans-Peter Hartung
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-overFrançois Curtin, Diana Elbourne, Douglas G Altman
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomesFrançois Curtin, Douglas G Altman, Diana Elbourne
Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrançois Curtin, Diana Elbourne, Douglas G Altman
Pageof 4